Should medical treatment for gender transition be available to children?

Medical treatment for gender transition should be available to children who need it, following the same principles that guide all paediatric healthcare. Research consistently shows that when young people experience gender dysphoria, access to appropriate medical care can significantly improve their mental health and quality of life.

Evidence indicates that denying treatment based solely on age can cause considerable harm and distress. Healthcare guidelines emphasise that transgender young people deserve the same access to medical care as children with any other health condition. The principle that medicine should be available to everyone who needs it, without discrimination based on age, gender, or other factors, applies equally to transgender healthcare.

Treatment approaches vary depending on the young person's age and individual circumstances. For prepubertal children, social transition and psychological support are typically the focus. For adolescents, evidence-based treatments may include puberty blockers and, in appropriate cases, hormone therapy. Guidelines recommend that decisions should always involve the young person, their family, and experienced healthcare professionals working together.

The goal is always to provide compassionate, evidence-based care that supports each young person's wellbeing and development. Families navigating these decisions deserve access to experienced professionals who can provide appropriate guidance and support throughout the process.